Edition:
India

China Meheco Co Ltd (600056.SS)

600056.SS on Shanghai Stock Exchange

23.46CNY
17 Jan 2018
Change (% chg)

¥-0.10 (-0.42%)
Prev Close
¥23.56
Open
¥23.65
Day's High
¥23.77
Day's Low
¥23.28
Volume
6,057,483
Avg. Vol
6,474,588
52-wk High
¥29.26
52-wk Low
¥19.56

Select another date:

Fri, Dec 29 2017

BRIEF-China Meheco Sells 7.2 Million Shares In China Merchants Bank As Of Dec

* SAYS IT HAS SOLD 7.2 MILLION SHARES IN CHINA MERCHANTS BANK AS OF DEC, RECEIVES NET INVESTMENT PROFIT OF ABOUT 128 MILLION YUAN ($19.66 million) Source text in Chinese: http://bit.ly/2C7C4qp Further company coverage: ($1 = 6.5100 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-China Meheco unit to set up pharmaceutical commerce JV in Hubei

* Says co's Hubei-based pharmaceutical unit plans to invest 5.1 million yuan to set up a Hubei-based pharmaceutical commerce JV, with registered capital of 10 million yuan

BRIEF-China Meheco unit to invest 5.1 mln yuan to set up hematodialysis JV in Guangdong

* Says Guangdong-based medicine unit will invest 5.1 million yuan to set up a hematodialysis JV in Guangdong and hold 51 percent stake in the JV after transaction

BRIEF-China Meheco says change of corporate auditor

* Says it plans to name Grant Thornton as corporate auditor for 2017

BRIEF-Pharmaceutical firm China Meheco's board elects chairman

Oct 9 China Meheco Co Ltd * Says board elects Jiang Xin as chairman Source text in Chinese: http://bit.ly/2hYjY0W Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-China Meheco unit gets approval for drug clinical trials

* Says its unit received drug clinical trials approval for its injection, which is mainly used for treatment of lung cancer and breast cancer

BRIEF-China Meheco's H1 net profit up 28.05 pct y/y at 652.65 mln yuan

* Says H1 net profit up 28.05 percent y/y at 652.65 million yuan ($97.94 million)

Select another date: